248 related articles for article (PubMed ID: 12785871)
1. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
Proell S
BioDrugs; 2003; 17 Suppl 1():7-10. PubMed ID: 12785871
[No Abstract] [Full Text] [Related]
2. Combined vaccination against hepatitis A, hepatitis B, and typhoid fever: safety, reactogenicity, and immunogenicity.
Proell S; Maiwald H; Nothdurft HD; Saenger R; Vollmar J; De Clercq N; von Sonnenburg F
J Travel Med; 2002; 9(3):122-6. PubMed ID: 12088576
[TBL] [Abstract][Full Text] [Related]
3. Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines.
Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Sänger R
BioDrugs; 2003; 17 Suppl 1():15-8. PubMed ID: 12785873
[No Abstract] [Full Text] [Related]
4. Comparison of two combined vaccines against typhoid fever and hepatitis A in healthy adults.
Beeching NJ; Clarke PD; Kitchin NR; Pirmohamed J; Veitch K; Weber F
Vaccine; 2004 Nov; 23(1):29-35. PubMed ID: 15519704
[TBL] [Abstract][Full Text] [Related]
5. Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years.
Overbosch D; Peyron F; Picot N; Varichon JP; Dumas R; Chambonneau L; Weber F
J Travel Med; 2005; 12(6):319-26. PubMed ID: 16343383
[TBL] [Abstract][Full Text] [Related]
6. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
Van Damme P; Van Herck K
Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
[TBL] [Abstract][Full Text] [Related]
7. [The immunological effectiveness and reactogenicity of the vaccine "HEP-A+B-in-VAC" against hepatitis A and B].
Chuĭkova KI; Gordetskaia EL; Gorbunov MA; Maĭdaniuk AG; Pomytkina MI
Vopr Virusol; 2006; 51(1):31-3. PubMed ID: 16515040
[TBL] [Abstract][Full Text] [Related]
8. A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults.
Loebermann M; Kollaritsch H; Ziegler T; Rendi-Wagner P; Chambonneau L; Dumas R; Lafrenz M
Clin Ther; 2004 Jul; 26(7):1084-91. PubMed ID: 15336473
[TBL] [Abstract][Full Text] [Related]
9. A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity.
Beran J; Beutels M; Levie K; Van Damme P; Dieussaert I; Gillet M; Van Hoecke C; Tornieporth N
J Travel Med; 2000; 7(5):246-52. PubMed ID: 11231208
[TBL] [Abstract][Full Text] [Related]
10. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
Roberton D; Marshall H; Nolan TM; Sokal E; Díez-Domingo J; Flodmark CE; Rombo L; Lewald G; Flor Jde L; Casanovas JM; Verdaguer J; Marés J; Esso DV; Dieussaert I; Stoffel M
Vaccine; 2005 Oct; 23(43):5099-105. PubMed ID: 16055231
[TBL] [Abstract][Full Text] [Related]
11. The tolerability of a combined hepatitis A and typhoid vaccine in children aged 2-16 years: an observational study.
Lau CL; Streeton CL; David MC; Sly PD; Mills DJ
J Travel Med; 2016 Feb; 23(2):tav023. PubMed ID: 26883924
[TBL] [Abstract][Full Text] [Related]
12. [Results of Russian multicenter trial of immunogenicity, reactogenicity and safety of new combination vaccine against hepatitis A and B (Twinrix)].
Tatochenko VK; Il'ina NI; Romanenko VV; Alikova OA; Fassakhov RS; Miasnikova TN; Patlusova VV; Zima IuIu; Reshetnikova ID; Frolova GS; Smolenov IV
Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):30-5. PubMed ID: 17163135
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
[TBL] [Abstract][Full Text] [Related]
15. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
Beran J
Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
17. Combined hepatitis A and B vaccine: providing a bright future for preventing hepatitis.
Hewlett AT
Expert Opin Biol Ther; 2009 Sep; 9(9):1235-40. PubMed ID: 19601727
[TBL] [Abstract][Full Text] [Related]
18. [Patient's information. Vaccination against hepatitis A and B in chronic liver diseases].
Moreira VF; Garrido E
Rev Esp Enferm Dig; 2011 Jan; 103(1):42. PubMed ID: 21341939
[No Abstract] [Full Text] [Related]
19. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study.
Burgess MA; Rodger AJ; Waite SA; Collard F
Vaccine; 2001 Sep; 19(32):4835-41. PubMed ID: 11535336
[TBL] [Abstract][Full Text] [Related]
20. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
